Todos Medical (Todos Medical) Common Stock : $4.05 Mil (As of Sep. 2022)

View and export this data going back to 2017. Start your Free Trial

What is Todos Medical Common Stock?

Todos Medical's quarterly common stock increased from Mar. 2022 ($0.00 Mil) to Jun. 2022 ($3.56 Mil) and increased from Jun. 2022 ($3.56 Mil) to Sep. 2022 ($4.05 Mil).

Todos Medical's annual common stock increased from Dec. 2019 ($0.28 Mil) to Dec. 2020 ($1.06 Mil) and increased from Dec. 2020 ($1.06 Mil) to Dec. 2021 ($2.91 Mil).

Todos Medical Common Stock Historical Data

The historical data trend for Todos Medical's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Todos Medical Common Stock Chart

Todos Medical Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Common Stock

Get a 7-Day Free Trial

0.19

0.28

1.06

2.91

Todos Medical Quarterly Data
	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Common Stock	Get a 7-Day Free Trial												2.59	2.91	-	3.56	4.05

Todos Medical Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Todos Medical (Todos Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Todos Medical Ltd (OTCPK:TOMDF) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

121 Derech Menachem Begin, 30th Floor, Tel Aviv, ISR, 6701203

Website

https://www.todosmedical.com

Todos Medical Ltd is an in vitro diagnostics company. Its operating segments are Breast Cancer Test, Alzheimer's, and COVID-19 testing. The company generates all of its revenue from the United States.

Executives

Gerald Commissiong	director, officer: CEO and Director	675 ALMANOR AVENUE, SUNNYVALE CA 94085
Strategic Investment Holdings, Llc	10 percent owner	875 CARRETERA 693, SUITE 201, DORADO PR 00646